Immunotherapy in Sarcoma & LMS

Immunotherapy for Sarcoma & LMS

Below are curated links and the verbatim block you provided, placed directly on the page (no archive) for easy reading.

LMS Immunotherapy Updates / Clinical Trials

LMS IMMUNOTHERAPY UPDATES/CLINICAL TRIALS

 

How is Immunotherapy Changing the Outlook for Patients with Sarcoma?

 

Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery

Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high-grade leiomyosarcomas supports immunotherapeutic strategies

An Early-Stage Trial of Immunotherapy for Advanced Sarcomasvideo by Dr. Arun Singh, 2015

CRI – Sarcoma Immunotherapy – Cancer Research Institute

Current and ongoing immunotherapy treatments hold promise  for sarcomas – in particular, these studies are looking at Leiomyosarcomas and pleomorphic sarcoma

 

Leiomyosarcoma: Immunotherapy Clinical Trials  video by Dr. Bartosz Chmielowski, 2017

Dr. Wilky on Immunotherapy Trial in Sarcoma by Dr. Wilky, 2017

Efficacy With PD-1 Inhibitor in Uterine Leiomyosarcoma  video by Dr. Suzanne George, 2017

Exceptional Responder to Pembrolizumab Guides Immunotherapy Progress in Leiomyosarcoma

First extensive immune profiling of sarcomas shows some likely susceptible to immunotherapy

Immunotherapy to Treat Cancer

PD-L1 and Immunotherapy – An overview

Web presentations on Immunotherapy for Sarcoma / Leiomyosarcoma:

Immune responses from early study of novel sarcoma vaccine

Immunotherapy with single-agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes

Cancer immunotherapy webinars

The full series of monthly immunotherapy webinars from Cancer Research Institute.

Below is a video explanation of Checkpoint Inhibitors which is currently being explored for LMS.

Expert Videos

Key presentations referenced above from Drs. Singh, Chmielowski, Wilky, and George.

Foundational Resources

• NCI: Immunotherapy to Treat Cancer
• CRI: Immunotherapy for Sarcoma

Checkpoint Inhibitors

Background video and context provided in the section above.